FDA
-
-
-
-
-
-
-
Japan approves Merck's subcutaneous pembrolizumab for all Keytruda uses
-
-
-
-
-
-
-
Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients Wi
-
-
-
-
-
-
-
Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure
-
-
-
-
-
-
-
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR)
-
-
-
-
-
-
-
FDA approves Merck's Keytruda combo with Trodelvy for TNBC
-
-
-
-
-
-
-
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
-
-
-
-
-
-
-
Apotex launches sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, eligible for 180-day shared exclusivity
-
332,798 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All
